JP2005533811A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533811A5
JP2005533811A5 JP2004516055A JP2004516055A JP2005533811A5 JP 2005533811 A5 JP2005533811 A5 JP 2005533811A5 JP 2004516055 A JP2004516055 A JP 2004516055A JP 2004516055 A JP2004516055 A JP 2004516055A JP 2005533811 A5 JP2005533811 A5 JP 2005533811A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
aryl
heteroaryl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004516055A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533811A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/019585 external-priority patent/WO2004000821A1/en
Publication of JP2005533811A publication Critical patent/JP2005533811A/ja
Publication of JP2005533811A5 publication Critical patent/JP2005533811A5/ja
Pending legal-status Critical Current

Links

JP2004516055A 2002-06-20 2003-06-20 5−(1,3−オキサゾル−2−イル)安息香酸誘導体の調製方法 Pending JP2005533811A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US45047803P 2003-02-27 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (2)

Publication Number Publication Date
JP2005533811A JP2005533811A (ja) 2005-11-10
JP2005533811A5 true JP2005533811A5 (cg-RX-API-DMAC7.html) 2006-07-20

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004516055A Pending JP2005533811A (ja) 2002-06-20 2003-06-20 5−(1,3−オキサゾル−2−イル)安息香酸誘導体の調製方法

Country Status (17)

Country Link
US (2) US7115747B2 (cg-RX-API-DMAC7.html)
EP (1) EP1532123B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005533811A (cg-RX-API-DMAC7.html)
CN (1) CN1324017C (cg-RX-API-DMAC7.html)
AT (1) ATE370131T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003249344A1 (cg-RX-API-DMAC7.html)
BR (1) BR0312439A (cg-RX-API-DMAC7.html)
CA (1) CA2489988A1 (cg-RX-API-DMAC7.html)
CO (1) CO5670350A2 (cg-RX-API-DMAC7.html)
DE (1) DE60315664D1 (cg-RX-API-DMAC7.html)
EA (1) EA008389B1 (cg-RX-API-DMAC7.html)
IL (1) IL165763A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04012630A (cg-RX-API-DMAC7.html)
NO (1) NO20045497L (cg-RX-API-DMAC7.html)
NZ (1) NZ537390A (cg-RX-API-DMAC7.html)
PL (1) PL374999A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004000821A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040762A1 (es) * 2002-11-27 2004-11-06 Elan Pharm Inc Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer
TW200738701A (en) * 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
EP1971598A1 (en) 2005-11-21 2008-09-24 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) * 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US20080277393A1 (en) * 2007-05-07 2008-11-13 True Charles W Collapsible, stackable, semi-rigid universal cotainer for hazardous and non-hazardous goods
CL2008001500A1 (es) 2007-05-25 2008-12-26 Amgen Inc Compuestos derivados de hidroxietil amina sustituidas, moduladores de betasecretasa; proceso de preparacion de dichos c ompuestos; composicion farmaceutica que los comprende; y su uso para tratar un trastorno neurologico, tal como alzheimer, sindrome de down, demencia degenerativa, entre otros.
CA2687608C (en) 2007-05-25 2013-07-02 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
MX2011002705A (es) 2008-09-11 2011-09-09 Amgen Inc Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso.
US8822485B2 (en) 2009-11-23 2014-09-02 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011063233A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011090911A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
MX2012010658A (es) 2010-03-15 2012-12-05 Amgen Inc Compuestos de anillo espiro tetraciclico como moduladores de beta-secretasa.
US8497264B2 (en) 2010-03-15 2013-07-30 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9346827B2 (en) 2011-02-07 2016-05-24 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020276A1 (es) * 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
CA2462851A1 (en) * 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
AR039555A1 (es) * 2001-11-08 2005-02-23 Upjohn Co Derivados n,n'-sustituidos de 1,3-diamino-2-hidroxipropano
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2005534614A5 (cg-RX-API-DMAC7.html)
RU2000127105A (ru) Соединения с активностью в отношении мускариновых рецепторов
RU2010133903A (ru) Способ и промежуточные соединения для получения производных 5-бифенил-4-ил-2-метилпентановой кислоты
JP2008523069A5 (cg-RX-API-DMAC7.html)
JP2008513432A5 (cg-RX-API-DMAC7.html)
JP2004532894A5 (cg-RX-API-DMAC7.html)
RU2007125710A (ru) Способ получения n-фенилпиразол-1-карбоксамидов
JP2021522280A5 (cg-RX-API-DMAC7.html)
JPS58185553A (ja) α−保護されたオキシイミノ−β−ケト−γ−ハロゲノ酪酸類
PE20021091A1 (es) Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
JP2003525286A5 (cg-RX-API-DMAC7.html)
AR084280A1 (es) Compuestos heterociclicos nitrogenados sustituidos fusionados en posicion 6,6 y usos de los mismos
EA200000334A1 (ru) Производные карбоксамидотиазолов, их получение, содержащие их фармацевтические композиции
RU2009109160A (ru) Инсектицидные изоксазолины
RU96105988A (ru) Замещенные арилоксиалкилдиамины, обладающие сосудосуживающим действием
JP2021532059A5 (cg-RX-API-DMAC7.html)
RU2012116525A (ru) Способы получения перемидиновых производных, пригодных в качестве ингибиторов протеинкиназ
JP2020535124A5 (cg-RX-API-DMAC7.html)
JP2006508147A5 (cg-RX-API-DMAC7.html)
RU2004101053A (ru) Способ и промежуточные соединения для получения латанопроста
JP2008518900A5 (cg-RX-API-DMAC7.html)
JP2022508642A5 (cg-RX-API-DMAC7.html)
AR043062A1 (es) Ureas sustituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer
JP2009501234A5 (cg-RX-API-DMAC7.html)
JP2025508971A5 (cg-RX-API-DMAC7.html)